Introduction
============

Basement membranes are thin, sheetlike structures that abut many cell types, including epithelia, endothelia, muscle, fat, and peripheral nerve. They serve as extracellular barriers and as substrates for cellular interactions. Basement membranes are assembled through complex interactions among the major components: laminins, collagen IV, perlecan, and nidogens ([@bib52]). Of these components, it is well-known that laminins regulate various cellular functions such as adhesion, motility, growth, differentiation, and apoptosis through interactions with specific cell surface receptors ([@bib2]; [@bib6]). All laminins are composed of three subunits, designated α, β, and γ chains. Five α, four β, and three γ chains have been identified. To date, 15 different laminin heterotrimers have been found to be synthesized and secreted by cells ([@bib4]; [@bib32]; [@bib18]; [@bib23]), although many more combinations are theoretically possible. Of the three laminin chain types, only the α chain has a large COOH-terminal globular (G)[\*](#fn1){ref-type="fn"} domain consisting of a tandem array of five small laminin-type globular (LG) modules LG1 through LG5 ([@bib53]). These LG modules contain binding sites for β1 integrins and heparin, as well as for α-dystroglycan and the Lutheran blood group glycoprotein (Lu) in some isoforms ([@bib50]; [@bib17]). Therefore, laminin α chains play pivotal roles in laminin-mediated cellular functions.

Genetic inactivation of laminin α chains has also demonstrated that they have specific functions. Mutation in laminin α2 results in congenital muscular dystrophy ([@bib11]). Mutations in laminin-5 (α~3~β~3~γ~2~) subunits lead to junctional epidermolysis bullosa, a severe skin blistering disease ([@bib42]). Targeted deletion of laminin α4 leads to impaired microvessel maturation and aberrant localization of neuromuscular synaptic specializations ([@bib41]; [@bib51]). We have shown that mice lacking laminin α5 die during late embryogenesis with several developmental defects, including defects in neural tube closure, digit separation, placentation, and kidney and lung development ([@bib33]; [@bib30]; [@bib36]).

In the kidney, basement membranes serve both as structural barriers for tubular epithelia and as a component of the glomerular filter. The glomerular basement membrane (GBM) contains an atypical assortment of basement membrane protein isoforms, including laminin-11 (α5β2γ1) and collagen α3--α5(IV) ([@bib26], [@bib27]). There are transitions in the basement membrane component isoforms that are deposited in the developing GBM ([@bib26]). During glomerulogenesis, transition of laminin isoforms is especially drastic ([@bib32]; [@bib46]). The nascent GBM initially contains laminin-1 (α1β1γ1) and laminin-8 (α~4~β~1~γ~1~), and laminin-10 (α~5~β~1~γ~1~) joins them at the S-shape stage. By the capillary loop stage, laminin-1 is eliminated from the GBM, and then laminin-9 (α~4~β~2~γ~1~) and laminin-11 (α~5~β~2~γ~1~) begin to accumulate. At maturity, only components of laminin-11 are detected in the GBM ([@bib26], [@bib27]). We have previously shown that mice lacking laminin α5 exhibit avascular glomeruli associated with breakdown of the GBM during glomerulogenesis ([@bib30]). This defect correlates with failure of the developmental switch in laminin α chain deposition in which α5 replaces α1 in the GBM at the capillary loop stage. However, the specific role of laminin α5 in the glomerulus is still undefined.

To investigate domain-specific functions of laminin α5 in developing glomeruli, we analyzed transgenic mice that express chimeric laminin α chains: Mr51 is composed of laminin α5 domains VI through I fused to the human laminin α1 G domain; and Mr5G2 is composed of α5 domains VI through LG2 fused to human α1LG3-5. These chimeras were expressed on the genetic background of the laminin α5 knockout (*Lama5* −/−). The developing kidney was analyzed by immunohistochemistry and transmission electron microscopy. We found that the adhesion of mesangial cells to the GBM via the G domain of laminin α5 plays a key role in capillary loop formation during glomerular development. In vitro studies suggested that integrin α~3~β~1~ and Lu are the receptors that mediate binding of mesangial cells to laminin α5.

Results
=======

The developmental switch from laminin α1 to α5 during glomerular development
----------------------------------------------------------------------------

As described in previous papers, transitions in laminin isoform deposition are quite dynamic during kidney development and maturation of the GBM ([@bib29]; [@bib32]; [@bib46]). A crucial developmental switch in laminin α chain deposition occurs in the GBM when the laminin α1 chain, which is predominantly expressed in basement membranes of the S-shape body, is replaced by laminin α5 in the capillary loop stage GBM ([Fig. 1](#fig1){ref-type="fig"} , A--D). In *Lama5* −/− mutant glomeruli, where this switch cannot occur, the kidney exhibits avascular glomeruli associated with GBM breakdown ([Fig. 1, E and F](#fig1){ref-type="fig"}). The GBM breaks down because laminin α1 is eliminated even in the absence of α5 expression, and without a compensating full-length laminin α chain, basement membrane structure cannot be maintained. As a result of GBM breakdown, the cells that comprise the glomerulus----podocytes, endothelial cells, and mesangial cell----are unable to maintain their proper positions adjacent to the GBM, resulting in failed glomerulogenesis ([@bib30]). This demonstrates the extreme importance of cell--matrix interactions during glomerulogenesis.

![**Laminin** α **chain switching and its importance during glomerulogenesis.** From the S-shaped to the capillary loop stage of glomerular development, the laminin α1 chain (A and B) is replaced by the laminin α5 chain (C and D) in the GBM, though α1 continues to be expressed by proximal tubules seen in B. (E and F) Targeted mutation of *Lama5* prevented this developmental transition, resulting in GBM breakdown and failed vascularization of glomeruli. Sections shown are toluidine blue--stained plastic sections of E18.5 control and *Lama5* −/− kidneys. S, S-shaped structure; G, glomerulus. Bars: (A and C) 100 μm; (B and D--F) 50 μm.](200211121f1){#fig1}

Expression of the chimeric laminin α chains, Mr51 and Mr5G2, in glomeruli
-------------------------------------------------------------------------

To begin to examine domain-specific functions of laminin α5, we produced transgenic mice expressing two different full-length chimeric laminin α chains. These encoded laminin α5 domains VI through I and VI through LG2 fused to the complete human laminin α1 G domain and α1LG3-5, designated Mr51 and Mr5G2, respectively ([Fig. 2, B and C](#fig2){ref-type="fig"}) . We chose to use the human rather than mouse α1 G domain because of the availability of mouse monoclonal antibodies specific for the human domain ([@bib55]); thus, transgene-derived proteins could be specifically localized in transgenic mouse tissues. A transgene encoding the full-length mouse α5 chain, designated Mr5 ([Fig. 2](#fig2){ref-type="fig"} A), served as a control. The widely active regulatory element miw ([@bib49]) was used to drive transgene expression. As described in our previous papers, transgene-derived laminin levels were significantly increased in heart and skeletal muscle ([@bib34]; [@bib17]). Crossing of the Mr5 transgene onto the *Lama5* −/− background revealed that transgene-derived laminin α5 was deposited widely in basement membranes. Expression was sufficient to fully rescue all known *Lama5* −/− embryonic defects in two independent lines, and the resulting *Lama5* −/−; Mr5 mice are viable and fertile (unpublished observations). These results show that the miw regulatory element directs expression of the transgene in a manner sufficient to replace the missing endogenous α5 wherever it is necessary.

![**Structure of wild-type and chimeric laminin chains.** The domains present in full-length laminin α5 (A), in the chimeric laminin α chains (B and C), and in full--length human α1 (D) are shown. (B) Mr51 contains human laminin α1 G domain linked to domains VI through I of mouse laminin α5. (C) Mr5G2 contains laminin α5 domains VI through α5 LG2 fused to the human laminin α1LG3-5 domain. Anti--mouse laminin α5 (\*) and anti--human laminin α1 LG1--2 (\*\*) antibody epitopes are indicated.](200211121f2){#fig2}

Expression of the two chimeric laminins was also widespread, as determined by staining with the anti--human α1 LG1--2 and LG4--5 domain antibodies ([@bib17]; [Fig. 3](#fig3){ref-type="fig"} ; unpublished data). The Mr51 and Mr5G2 transgenes were separately mated onto the *Lama5* mutant genetic background, but the resulting *Lama5* −/−; Mr51 and *Lama5* −/−; Mr5G2 mice were not viable. *Lama5* −/−; Mr51 embryos exhibited the same defects we initially reported for *Lama5* −/− embryos ([@bib33]), but the incidence of exencephaly was reduced from 60% to \<10%. On the other hand, although defects in digit septation were still observed, the Mr5G2 transgene improved the growth of *Lama5* −/− embryos, which are usually smaller than controls ([@bib33]). This indicates that the chimeric proteins have limited functions, and that the G domain of α1 cannot fully compensate for the missing α5 G domain.

![**Expression of the chimeric** α **chains, Mr51 and Mr5G2, in transgenic mice.** Micrographs show E17.5 glomeruli from *Lama5* −/− (A and B), *Lama5* −/−; Mr5 (C and D), *Lama5* +/−; Mr51 (E and F), *Lama5* −/−; Mr51 (G and H), *Lama5* +/−; Mr5G2 (I and J), and *Lama5* −/−; Mr5G2 (K and L) embryos. Sections were doubly stained with an antiserum to domains IIIb/IVa of laminin α5 (A, C, E, G, I, and K) and a mouse monoclonal antibody specific for human laminin α1 LG1--2 (B, D, F, H, J, and L). Although the chimeric laminins were assembled into the GBM, *Lama5* −/−; Mr51 and *Lama5* −/−; Mr5G2 glomeruli exhibited distended capillaries (G, H, and K). Arrowheads indicate the GBM. Bar, 50 μm.](200211121f3){#fig3}

In fetal kidney, Mr51 and Mr5G2 were detected in the GBM on both the control and *Lama5* −/− genetic backgrounds ([Fig. 3](#fig3){ref-type="fig"}, F--H and K), suggesting that incorporation of the chimeric laminin chains into the GBM might be capable of preventing the breakdown normally observed in *Lama5* −/− glomeruli. There was no apparent effect of the chimeric laminins on *Lama5* +/− control glomeruli ([Fig. 3, E, F, and I](#fig3){ref-type="fig"}), and the mice were healthy. However, the glomeruli of *Lama5* −/−; Mr51 and *Lama5* −/−; Mr5G2 embryos exhibited greatly reduced or absent capillary looping ([Fig. 3, G, H, and K](#fig3){ref-type="fig"}).

Identification of cell types in glomerular structures
-----------------------------------------------------

To further investigate the effects of Mr51 and Mr5G2 on glomerulogenesis, we used cell type--specific antibodies to identify the three cell types found in glomeruli. Frozen sections of E17.5 control, *Lama5* −/−, *Lama5* −/−; Mr51, and *Lama5* −/−; Mr5G2 kidneys were stained with antibodies to WT1, platelet endothelial cell adhesion molecule (PECAM), and desmin to label podocytes, endothelial cells, and mesangial cells, respectively ([Fig. 4](#fig4){ref-type="fig"} , green), and doubly labeled with an anti--basement membrane antibody ([Fig. 4](#fig4){ref-type="fig"}, red). In the control, podocytes were observed in a single cell layer epithelium adjacent to the glomerular capillaries ([Fig. 4](#fig4){ref-type="fig"} A), and mesangial cells, which provide tension to maintain the glomerular capillary loop structure, were found associated with endothelial cells in the interior of the glomerulus ([Fig. 4](#fig4){ref-type="fig"} I). In the *Lama5* −/− mutant, the podocytes were in disarray, and the endothelial cells and mesangial cells were extruded from glomerulus, as we showed previously ([@bib30]; [Fig. 4, B, F, and J](#fig4){ref-type="fig"}). In *Lama5* −/−; Mr51 glomeruli, the transgene-derived chimeric laminin chain partially rescued the defects observed in the mutant. The podocytes were arranged in a single cell layer ([Fig. 4](#fig4){ref-type="fig"} C), and the endothelial cells and mesangial cells were localized in the interior of the glomerulus, similar to the control ([Fig. 4, G and K](#fig4){ref-type="fig"}). These results suggest that the COOH-terminal portion of laminin α5 is dispensable for the assembly of the GBM and arrangement of podocytes. However, the great reduction in capillary looping ([Fig. 4, C and K](#fig4){ref-type="fig"}) is indicative of a mesangial cell defect because a similar phenotype has been observed in the total absence of mesangial cells in mice lacking either PDGF B or PDGF receptor β ([@bib24]). *Lama5* −/−; Mr5G2 glomeruli exhibited a very similar aberrant glomerular phenotype ([Fig. 4, D, H, and L](#fig4){ref-type="fig"}).

![**Identification and localization of cell types in developing glomeruli.** E17.5 control, *Lama5* −/−, *Lama5* −/−; Mr51, and *Lama5* −/−; Mr5G2 frozen kidney sections (as indicated) were stained with antibodies to WT1 to label podocytes (A--H, green), PECAM to label endothelial cells (E--H, red), and desmin to label mesangial cells (I--L, green). Basement membranes were stained with anti--laminin γ 1 monoclonal antibody (A--D, red) or anti--laminin-1 polyclonal antibody (I--L, red). In *Lama5* −/−; Mr51 or Mr5G2 glomeruli, the podocytes were arranged properly in a single cell layer at the periphery (C and D), and the glomerular endothelial cells were properly localized (G and H). However, defective capillary loop formation was observed, despite the presence of mesangial cells (K and L). Bar, 50 μm.](200211121f4){#fig4}

Analysis of glomerular ultrastructure and podocyte gene expression
------------------------------------------------------------------

To further investigate the fine structure of the GBM and adjacent cells, we used transmission electron microscopy to visualize E17.5 control, *Lama5* −/− and *Lama5* −/−; Mr51 glomeruli ([Fig. 5](#fig5){ref-type="fig"}) . In the control, the GBM was clearly visible between podocytes and endothelial cells ([Fig. 5, A and G](#fig5){ref-type="fig"}). Mesangial cells were attached to the GBM at the bases of the capillary loops ([Fig. 5](#fig5){ref-type="fig"} D); this allows them to maintain the glomerular capillary loop structure. In the *Lama5* −/− glomerulus, the absence of laminin α5, coupled with the programmed disappearance of laminin α1, resulted in breakdown of the GBM by the late capillary loop stage ([Fig. 5, B and E](#fig5){ref-type="fig"}). In the *Lama5* −/−; Mr51 glomerulus, the ultrastructure of the GBM was similar to that observed in control ([Fig. 5, C and H](#fig5){ref-type="fig"}), confirming that the transgene-derived chimeric laminin α chain must have been assembled into the GBM, as previously demonstrated by immunofluorescence ([Fig. 3](#fig3){ref-type="fig"}). This suggests that the short and long arm regions of laminin α5 are sufficient for directing incorporation of the chimera into the GBM. Although podocytes extended foot processes in both control and *Lama5* −/−; Mr51 glomeruli ([Fig. 5, A, C, G, and H](#fig5){ref-type="fig"}), there appeared to be fewer processes in the latter. This may suggest that the α5 G domain has some role in inducing process extension. However, slit diaphragms, the delicate tight and adherens junctions--related structures that are required for glomerular filtration ([@bib13]; [@bib28]), were observed between many of those foot processes that did form ([Fig. 5](#fig5){ref-type="fig"} H), indicating that this crucial aspect of podocyte differentiation was progressing appropriately. To investigate this in more detail, we used antibodies to slit diaphragm-- and foot process--associated proteins. The results were essentially similar for the three genetic backgrounds; all podocytes expressed nephrin, CD2AP, podocin, and synaptopodin (unpublished data). The straightforward interpretation is that neither GBM composition nor its integrity is relevant for expression of these proteins. However, it is important to note that initiation of expression of these proteins has been shown to occur as early as the S-shape stage of glomerular development, when the GBM is structurally sound even in the *Lama5* −/− background. Thus, we cannot rule out the possibility that podocyte interactions with the basement membrane at early stages are required for their proper differentiation and gene expression in vivo.

![**Ultrastructural analysis of glomeruli.** Low and high magnification electron micrographs show E17.5 glomeruli from control, *Lama5* −/−, and *Lama5* −/−; Mr51 kidneys, as indicated. The normally continuous basement membrane underlying the podocytes in control (A and G, arrowheads) was disrupted in the *Lama5* −/− mutant (B and E, arrows). The chimeric laminin Mr51 rescued assembly of the basement membrane and formation of podocyte foot processes on the *Lama5* −/− genetic background (C and H, arrowheads). In the control (D and I), mesangial cells (mc) bound the GBM (I, white line) to maintain the capillary loop (cl) structure. In *Lama5* −/−; Mr51 glomeruli (F and J), the ballooning of the capillaries, which were commonly filled with red blood cells (F, rbc), was associated with detachment of mesangial cells from the GBM (F, arrowheads; J, white line). However, podocytes (p) and endothelial cells (e) maintained their normal positions on either side of the GBM. To better present the structure of glomeruli, red blood cells were removed digitally in I and J.](200211121f5){#fig5}

Low power electron microscopic observations of *Lama5* −/−; Mr51 glomeruli revealed distension of the glomerular capillaries and detachment of mesangial cells from the GBM (compare [Fig. 5, F and J](#fig5){ref-type="fig"} with [Fig. 4, C and K](#fig4){ref-type="fig"}). We conclude that the binding of mesangial cells to the α5 G domain, which is absent in *Lama5* −/−; Mr51 glomeruli, is essential for maintenance of this normal capillary loop structure, an example of which is shown in the electron micrographs from control glomeruli (compare [Fig. 5, D and I](#fig5){ref-type="fig"} with [Fig. 4](#fig4){ref-type="fig"} I). No such structure was ever observed in *Lama5* −/− glomeruli ([Fig. 5](#fig5){ref-type="fig"} E; unpublished data), which are extremely disorganized ([@bib30]).

Molecular composition of the *Lama5* −/−; Mr51 glomerular basement membrane
---------------------------------------------------------------------------

The distended capillaries observed upon substitution of Mr51 transgene--derived protein for endogenous α5 could result from secondary defects in basement membrane composition. For example, [@bib20] recently reported that 10--40% of glomeruli in fibulin-1--deficient mice exhibit a similar capillary malformation. Thus, the distended capillaries in *Lama5* −/−; Mr51 glomeruli could be secondary to the failure of fibulin-1 to incorporate into the GBM. To investigate whether deposition of fibulin-1 or other GBM components was altered in *Lama5* −/−; Mr51 glomeruli, we stained E17.5 kidney sections from control and *Lama5* −/−; Mr51 fetuses with a panel of antibodies to GBM proteins ([Fig. 6](#fig6){ref-type="fig"} ; unpublished data). Fibulin-1 was detected in both the GBM and the mesangial matrix on the *Lama5* −/−; Mr51 background, suggesting that the distended capillary loops were not secondary to the absence of fibulin-1. We also examined the expression of fibulin-2, agrin, nidogen-1/entactin-1, nephronectin, perlecan, and the collagen α3(IV) and α4(IV) chains, and in no case was there a significant difference between control and *Lama5* −/−; Mr51 glomeruli ([Fig. 6](#fig6){ref-type="fig"}). Again, this suggested that the defects observed in *Lama5* −/−; Mr51 glomeruli are not due to the disappearance of other GBM or mesangial matrix components. However, we did find greatly reduced levels of the laminin β2 chain ([Fig. 7, E and G](#fig7){ref-type="fig"}) , whereas laminin β1 was present in both control and *Lama5* −/−; Mr51 maturing glomeruli ([Fig. 7, A and C](#fig7){ref-type="fig"}).

![**Deposition of ECM proteins in control and** *Lama5* −/−**; Mr51 glomeruli.** Sections of E17.5 control and *Lama5* −/−; Mr51 kidneys were stained with specific antibodies to fibulin-1 (A and B), fibulin-2 (C and D), agrin (E and F), nidogen-1/entactin-1 (G and H), nephronectin (I and J), perlecan (K and L), collagen α3(IV) (M and N), and collagen α4(IV) (O and P). The mutant GBM had a composition very similar to the control. Bar, 50 μm.](200211121f6){#fig6}

![**Expression of laminin β chains in glomeruli.** Sections of E17.5 control (A and E), *Lama5* −/− (B and F), *Lama5* −/−; Mr51 (C and G) and *Lama5* −/−; Mr5G2 (D and H) kidneys were stained with specific antibodies to laminin β1 (A--D) and β2 (E--H). Arrowheads indicate GBM. Laminin β2 was almost undetectable in *Lama5* −/−; Mr51 GBM (G), but Mr5G2 increased β2 accumulation (H), though it was somewhat lower than that in the control (E). Bar, 50 μm.](200211121f7){#fig7}

Laminin β2 normally trimerizes with the laminin α5 and γ1 chains to form laminin-11, which is first detected at the capillary loop stage of glomerulogenesis ([@bib29]; [@bib32]). The paucity of laminin β2 in *Lama5* −/−; Mr51 GBM indicates either that β2 does not efficiently associate with the Mr51 chimera to form a trimer, or that the trimer forms but does not efficiently incorporate into the GBM. On the other hand, β2 did efficiently incorporate into the GBM in the presence of Mr5G2 ([Fig. 7](#fig7){ref-type="fig"} H). Although little is known about how specificity of laminin trimerization or incorporation into basement membranes is determined, these results suggest that it may be encoded in the α chain G domain. Indeed, laminin α1 and β2 are only rarely found in the same basement membrane (unpublished observations), perhaps because the α1 G domain directs preferential assembly with β1. Nevertheless, the laminin-3 trimer (α~1~β~2~γ~1~) has been isolated from placenta ([@bib5]), suggesting that whatever code exists could be cell type--specific. In any event, although laminin β2 knockout mice exhibit a congenital nephrotic syndrome ([@bib38]), there is no capillary loop distension similar to that observed here. Thus, these capillary loop defects cannot be ascribed to lack of either β2 or any other GBM component for which we have antibodies. The straightforward conclusion is that mesangial cells organize the glomerular capillary loops by adhering to the G domain of laminin α5 in the GBM, and that they are unable to adhere to the α1 G domain modules present in the Mr51 and Mr5G2 chimeras. These results point to α5LG3--5 as necessary for effective mesangial cell adhesion.

Adhesion of mesangial cells to laminins in vitro
------------------------------------------------

To further investigate interactions between mesangial cells and the laminin α5 G domain, we turned to in vitro adhesion assays that used primary human and rat mesangial cells and purified laminin preparations. We have not yet been able to isolate laminin trimers containing the chimeric α chains, and G domain preparations were not available, so we chose to use commercially available laminins. First, we compared the abilities of laminin-10/11 (α~5~β~1~/~2~γ~1~) and laminin-1 (α~1~β~1~γ~1~) to promote adhesion of mesangial cells. Quantitative analysis of both human and rat mesangial cell adhesion to surfaces coated with increasing concentrations of these proteins showed that laminin-10/11 had higher cell adhesion activity than laminin-1, especially at the lower protein concentrations ([Fig. 8, A and B](#fig8){ref-type="fig"}) . In addition, the cells spread less well on laminin-1 than they did on laminin-10/11 (unpublished data). These data provide an explanation as to why mesangial cells adhere poorly to GBM containing the α1 G domain ([Fig. 5, F and J](#fig5){ref-type="fig"}) but adhere well to normal GBM containing the α5 G domain ([Fig. 5, D and I](#fig5){ref-type="fig"}). We believe that these in vitro data using laminin trimers justify our conclusions concerning adhesiveness of G domains because in vivo mesangial cells adhere to wild-type α5 but not to Mr51, which contains α5 domains VI through I. Thus, adhesion to laminin-10/11 trimers is likely mediated primarily by the α5 G domain.

![**Analysis of mesangial cell adhesion to laminins in vitro.** 96-well plates were coated with increasing concentrations of laminin-1 (closed squares) or laminin-10/11 (open circles) and incubated with mesangial cells at 37°C for 1 h. Human (A) and rat (B) mesangial cells readily attached to laminin-10/11, but were significantly less adherent to laminin-1. (C) Identification of receptors mediating adhesion of mesangial cells to laminin-10/11. Human mesangial cells preincubated with function-blocking antibodies against the indicated integrin subunits were added to laminin-10/11--coated wells. Values are expressed as percentages of the number of cells adhering in the absence of monoclonal antibodies. Each column represents the mean of triplicate assays. Error bars show the standard deviation. Anti--integrin α3 and β1 antibodies partially inhibited the adhesion of human mesangial cells to laminin-10/11, indicating that integrin α~3~β~1~ is a primary receptor. (D) The effect of sol-Lu on adhesion of human mesangial cells to laminin-10/11. Sol-Lu had little inhibitory effect on its own, but cooperated with anti--integrin β1 antibodies to inhibit adhesion by ∼90%. This indicates that Lu cooperates with integrin α~3~β~1~ to mediate mesangial cell adhesion to laminin α5 in the GBM.](200211121f8){#fig8}

Identification of receptors mediating mesangial cell adhesion to laminin-10/11
------------------------------------------------------------------------------

We next wished to investigate the mechanism of mesangial cell adhesion to the α5 G domain. Cell adhesion to laminin-10/11 is mediated predominantly by the integrin family of adhesion receptors ([@bib15], [@bib16]). Therefore, we examined the effects of function-blocking monoclonal antibodies against various integrin subunits on human mesangial cell adhesion to laminin-10/11 ([Fig. 8](#fig8){ref-type="fig"} C). Anti--integrin α3 and β1 antibodies significantly inhibited the adhesion of human mesangial cells to laminin-10/11. On the other hand, monoclonal antibodies to integrin α1, α2, and α6 had no effect on adhesion, even when combined with the anti--integrin α3 antibody ([Fig. 8](#fig8){ref-type="fig"} C). Together, these results indicate that integrin α3β1 is one primary receptor that mesangial cells use to adhere to laminin-10/11.

Recently, it has been reported that Lu, a member of the Ig superfamily, is a potential nonintegrin receptor for the laminin α5 chain ([@bib22]; [@bib54]; [@bib40]). A splice variant of Lu present in humans that should also bind laminin α5 is known as basal cell adhesion molecule ([@bib8]; [@bib57]). In our previous studies, we showed that Lu is expressed on the surface of a subset of muscle and epithelial cells in diverse tissues adjacent to basement membranes containing the laminin α5 chain ([@bib34]). We have also identified Lu to be a specific receptor for laminin α5 via binding to the α5 G domain by using a recombinant form of soluble Lu (sol-Lu) that contains only the Lu extracellular domain; in addition, the presence of α5LG3 was required for binding ([@bib17]). Lu was coexpressed with integrin α3 on mouse mesangial cells in vivo (unpublished data). To examine whether Lu is also involved in adhesion of mesangial cells to laminin α5, sol-Lu was used in adhesion/inhibition assays ([Fig. 8](#fig8){ref-type="fig"} D). In theory, sol-Lu should bind Lu binding sites on laminin α5 and prevent the Lu present on mesangial cells from interacting with α5. Although sol-Lu alone had no effect on mesangial cell adhesion to laminin-10/11, a significant inhibitory effect was observed when it was combined with the anti--integrin β1 antibody ([Fig. 8](#fig8){ref-type="fig"} D). Thus, Lu may be a secondary receptor for adhesion of mesangial cells to laminin-10/11. In addition, the fact that sol-Lu did not enhance the anti--integrin α3 antibody inhibition suggests that there may be another integrin α subunit that is involved.

Discussion
==========

We and others have previously shown that the laminin α5 chain is widely expressed in mice ([@bib31], [@bib32]; [@bib47]). Based on knockout studies, laminin α5 has roles in several important developmental processes, including neural tube closure, digit septation, placentation, and lung and kidney development ([@bib33]; [@bib30]; [@bib36]). We found that most of the developmental defects are associated with basement membrane breakdown or discontinuity resulting from the absence of α5. Here, we have begun to investigate the role of laminin α5 using a combined transgenic/knockout approach, which effectively substitutes either all or part of the α5 G domain with analogous segments of α1. The result is expression of full-length chimeric laminin α chains capable of trimerizing with β and γ chains and incorporating into basement membranes. A similar strategy was previously used in vitro to map a synaptic basement membrane localization domain on the laminin β2 chain ([@bib25]). This approach has allowed us to uncover a laminin α5 G domain--specific function in glomerulogenesis that might never have been found through traditional knockouts. It also demonstrates the feasibility of using widely expressed transgenes encoding altered basement membrane proteins to replace existing knocked out genes, effectively generating knockins without the use of further gene targeting in ES cells.

Expression of the Mr51, and presumably Mr5G2, chimeric α chains on the *Lama5* −/− background was able to rescue the breakdown of the GBM ([Fig. 5](#fig5){ref-type="fig"}) that normally occurs in *Lama5* −/− glomeruli when laminin α1 is eliminated ([@bib30]). The mechanism of α1 elimination is unknown; but if it is not purely transcriptional, then it must somehow be selective for α1 because α5 is not eliminated. It is likely that primary sequence differences or domain structural differences account for the selective elimination of α1. The G domain of α1, present in Mr51, could have carried a signal for elimination, but our results suggest this not to be the case because Mr51 was not eliminated. We are continuing to investigate this interesting issue using additional α chain transgenes.

The major defect in the *Lama5* −/−; Mr51 and *Lama5* −/−; Mr5G2 embryos was ballooning of the glomerular capillaries. This same defect was observed in mice lacking mesangial cells due to absence of PDGFB/PDGF receptor β signaling ([@bib24]). However, in our case, mesangial cells were clearly present ([Fig. 4, K and L](#fig4){ref-type="fig"}, and [Fig. 5](#fig5){ref-type="fig"} J), so we concluded that they must not be adhering properly to the GBM to maintain capillary looping. As the only known differences between normal and *Lama5* −/−; Mr51/Mr5G2 GBMs are the G domain substitutions, and laminin α chain G domains have been shown to harbor recognition sites for numerous cell adhesion receptors ([@bib6]), we hypothesized that mesangial cells normally adhere to the α5 G domain but were unable to adhere tightly to either the complete α1 G domain or to α1 LG3--5. Our in vitro studies confirmed that both human and rat mesangial cells adhere better to α5-containing laminins than to α1-containing laminin ([Fig. 8, A and B](#fig8){ref-type="fig"}).

With regard to mechanisms for mesangial adhesion to the α5 G domain, mesangial cells express several β1 integrins, including α~1~β~1~, α~2~β~1~, α~3~β~1~, α~5~β~1~, α~6~β~1~, and α~8~β~1~ ([@bib10]; [@bib48]; unpublished observations). Furthermore, immuno-EM studies have shown that β1-containing integrins are concentrated at the mesangial cell surface adjacent to the GBM and the mesangial matrix ([@bib14]). Antibody inhibition studies demonstrated that integrin α~3~β~1~ plays a major role in mesangial cell adhesion to laminin-10/11 ([Fig. 8](#fig8){ref-type="fig"}). In support of this, the glomerular capillaries of *Itga3* −/− kidneys are dilated ([@bib21]), suggesting a defect in mesangial adhesion to the GBM but the fact that the capillaries are not ballooned suggests that another receptor normally cooperates with α~3~β~1~ and is able to partially compensate in *Itga3* −/− mesangial cells. We found that Lu is expressed on mouse mesangial cells and cooperates with β1 integrins to mediate adhesion in vitro (unpublished data; [Fig. 8](#fig8){ref-type="fig"} D). The fact that Lu was found to be involved is consistent with the fact that Mr5G2 does not support capillary loop formation in vivo, because we have shown that sol-Lu does not bind Mr5G2 ([@bib17]). *Lu* mutant mice being generated in our laboratory will allow us to more directly address the function of Lu in glomerulogenesis.

An important issue to consider here is the relationship of mesangial cells with laminins in the mesangium, a non--basement membrane ECM, which mesangial cells secrete and in which they are embedded. Several different laminins are found in the mesangium, including substantial amounts of laminins-1 (α~1~β~1~γ~1~), -2 (α~2~β~1~γ~1~), and -10 (α~5~β~1~γ~1~), but others can be detected at lower levels ([@bib27]). It has not been possible to determine the relative levels of these laminins, but one would suspect that, based on our findings, decreased levels of laminin-10 or increased levels of laminin-1, as might occur in disease states, could correlate with reduced adhesion of mesangial cells to the mesangial matrix. On the other hand, the fact that mesangial cells are almost totally surrounded by their matrix may make this issue irrelevant, as weaker adhesion may be tolerated, both in disease and in normal states. This would be in contrast to the relationship of mesangial cells to the GBM, with which they make contact only at the bases of the capillary loops. A more robust adhesion to the GBM may be necessary in this setting of limited contact in order to counteract the force of blood pressure. Therefore, interaction with the G domain of α5, normally the only α chain in the GBM, would ensure a tight adhesion.

Two other laminin mutant mice with kidney defects have been described. In mice lacking laminin β2, the β1 chain compensates and allows an ultrastructurally normal basement membrane to form. However, the glomerular filter fails as a barrier to plasma proteins, and the mice die at 3 wk of age with massive proteinuria ([@bib38]). No defects in capillary looping were observed, consistent with the fact that laminin α5, as part of laminin-10 (α~5~β~1~γ~1~), is present in the GBM (unpublished observations); thus, mesangial cells should still be capable of binding to the GBM and maintaining capillary looping. On the other hand, mice lacking the binding site for nidogen on laminin γ1 exhibit glomerular capillary aneurysms similar to the ballooned capillaries we have reported here. The aneurysms were associated with GBM discontinuities ([@bib56]), and we suggest that these GBM defects prevent mesangial cells from adhering and maintaining the integrity of the capillary loops.

Integrin α~3~β~1~ is expressed basally on podocytes ([@bib19]; [@bib21]), yet detachment of podocytes from the GBM in *Lama5* −/− Mr51/Mr5G2 glomeruli, as occurred with mesangial cells, was not observed. There are two possibilities to explain this. First, integrin α~3~β~1~ on podocytes may serve primarily as a signal transducing receptor rather than as an anchoring one. Dystroglycan is also expressed on podocytes but not on mesangial cells (unpublished data), and together with Lu, this may be sufficient for adhesion of podocytes to the GBM. Second, podocytes and mesangial cells may be adhering only weakly to the chimeric laminins through integrin α~3~β~1~. This may be sufficient for long-term adhesion of podocytes to the GBM but not for mesangial cells. Capillary looping was evident in immature *Lama5* −/−; Mr51/Mr5G2 glomeruli, but mesangial cell adhesion to the GBM was apparently too weak to counteract the force of blood pressure, leading to de-adhesion and capillary ballooning. In support of this is our finding that adhesion activity of laminin-10/11 (α~5~β~1~/~2~γ~1~) was stronger than that of laminin-1 (α~1~β~1~γ~1~) for both human and rat mesangial cells ([Fig. 8, A and B](#fig8){ref-type="fig"}).

In conclusion, the laminin α5 chain plays a crucial role in maintaining glomerular capillary loop structure. We mapped the adhesive site in vivo to the LG3--5 modules of the G domain. Adhesion of mesangial cells to the laminin α5 G domain is mediated by integrin α~3~β~1~ and Lu. Mesangial cells express contractile proteins and are similar to smooth-muscle cells. Their frequency and extent of contraction in response to vasoactive substances are thought to determine the glomerular filtration rate. It is interesting to speculate that defective interactions between mesangial cells and laminin α5 in the GBM may be a feature of diverse glomerulopathies in the adult kidney.

Materials and methods
=====================

Proteins and antibodies
-----------------------

Mouse laminin-1 (α~1~β~1~γ~1~) and human laminin-10/11 (α~5~β~1~/β~2~γ~1~) were purchased from Invitrogen. Soluble recombinant Lu extracellular domain (sol-Lu) was produced and characterized as described previously ([@bib17]). Monoclonal antibody against human laminin α1 LG1--2 (161EB7) has been described previously ([@bib55]). Rat monoclonal antibody 8B3 to laminin α1 ([@bib1]) was a gift from Dr. D. Abrahamson (University of Kansas Medical Center, Kansas City, KS). Polyclonal antibodies against laminin-1 ([@bib44]) and agrin were gifts from Dr. J. Sanes (Washington University School of Medicine, St. Louis, MO). Rat monoclonal antibodies MAB1914 to laminin γ1, MAB1946 to entactin/nidogen-1, and MAB1948 to perlecan were purchased from CHEMICON International, Inc. Polyclonal antibodies against the following mouse laminins and fibulins were gifts from Drs. R. Timpl and T. Sasaki (Max-Planck Institute, Martinsried, Germany): domain VI of laminin α1, domain IV of laminin β1, domain IV of laminin β2, fibulin-1C, and fibulin-2 ([@bib39]; [@bib9]; [@bib45]). Rat monoclonal antibodies against collagen α3(IV) (H31) and α4(IV) (H43) chains have been described previously ([@bib37]). Rabbit antibody against nephronectin ([@bib3]) was a gift from Dr. L. Reichardt (University of California, San Francisco, San Francisco, CA). Rabbit antibody against domain IIIb/IVa of mouse laminin α5 was produced and characterized as described previously ([@bib32]). Rat monoclonal antibody MEC 13.3 to PECAM was purchased from BD Biosciences. Rabbit antiserum sc-192 to Wilms\' tumor protein (WT1) was purchased from Santa Cruz Biotechnology, Inc. Mouse monoclonal antibody D33 to desmin was purchased from DakoCytomation. Mouse monoclonal antibody to synaptopodin ([@bib35]) was a gift from Dr. P. Mundel (Albert Einstein College of Medicine, Bronx, NY). Rabbit antibodies to CD2AP, nephrin, and podocin have been described previously and were gifts from A. Shaw (Washington University School of Medicine), L. Holzman (University of Michigan Medical School, Ann Arbor, MI), and C. Antignac (Necker Hospital, Paris, France; [@bib7]; [@bib12]; [@bib43]). Monoclonal antibodies against human integrin α1 (FB12), α2 (P1E6), α3 (P1B5), and α6 (GoH3) were purchased from CHEMICON International, Inc.

Preparation of the chimeric laminin constructs
----------------------------------------------

Preparation of the chimeric laminin α chains, designated Mr51 and Mr5G2, has been described in [@bib17]. Both chimeric laminin cDNAs were cloned into a modified version of the widely active expression vector miw, which contains the RSV LTR inserted into the chicken β-actin promoter ([@bib49]).

Generation of knockout and transgenic mice
------------------------------------------

Production of *Lama5* mutant mice and of transgenic mice expressing a full-length laminin α5 transgene or the chimeric laminin transgenes has been described previously ([@bib33]; [@bib34]; [@bib17]). Five independent Mr51 lines, all of which gave similar results, and one Mr5G2 line were produced.

Immunohistochemistry
--------------------

For immunohistochemistry, mouse embryos from timed matings were frozen whole by immersing in OCT compound and quick-freezing in 2-methylbutane cooled in a dry ice ethanol bath. Sections were cut at 7 μm in a cryostat and air-dried. For staining, sections were blocked in 10% normal goat serum and incubated with primary antibody. All antibody incubations were in PBS containing 1% BSA, and all washes were in PBS. Secondary antibodies were conjugated to FITC (ICN Biomedicals) or Cy3 (CHEMICON International, Inc.). After several washes, sections were mounted in 90% glycerol containing 0.1× PBS and 1 mg/ml *p*-phenylenediamine. Sections were examined through a microscope (Eclipse E800; Nikon). Images were captured with a Spot 2 cooled color digital camera (Diagnostic Instruments) using Spot Software Version 2.1. Images were imported into Adobe Photoshop 5.0 and Adobe Illustrator 9.0 for processing and layout.

For semi-thin and thin sectioning, embryonic kidneys were fixed in 4% paraformaldehyde, 4% glutaraldehyde in 0.1 M cacodylate buffer and processed as described previously ([@bib38]). 2-μm sections were cut with a glass knife and stained with toluidine blue for light microscopy. Thin sections were cut with a diamond knife and stained with lead citrate plus uranyl acetate for transmission electron microscopy. Reagents were obtained from Polysciences Inc.

Cell culture and adhesion assay
-------------------------------

Normal human mesangial cells were purchased from Cambrex Life Science Corporation. Cells were grown in MsGM medium supplied by Cambrex Life Science Corporation and used within seven passages. Primary rat mesangial cells were provided by Q. Yu and A.R. Morrison (Washington University School of Medicine). Cells were grown in DME supplemented with 20% FBS, 10 μg/ml insulin, 1 mM glutamate, and 1 mM sodium pyruvate (Invitrogen) and used within seven passages. Adhesion assays were performed as described previously ([@bib16]). In brief, 20 μg/ml of commercial laminin-10/11 was coated onto a 96-well plate (Nunc) at 37°C for 1 h. The wells were blocked with 1% BSA. Mesangial cells were trypsinized and allowed to recover in serum-free medium for ∼30 min and 100 μl of mesangial cells at 10^5^ cells/ml in DME were added to the wells. After a 1-h incubation, the attached cells were stained with 0.2% crystal violet in 20% methanol for 10 min, 100 μl of 1% SDS was added to dissolve the cells, and absorbance was measured at 570 nm by VERSAmax (Molecular Devices). To identify the receptors for laminin-10/11, 10 μg/ml of monoclonal antibodies against different integrins and the recombinant sol-Lu protein were preincubated individually with mesangial cells in a volume of 50 μl of serum-free DME (5 × 10^3^ cells/well) at room temperature for 15 min. The preincubated cells were transferred to plates coated with laminin-10/11 and incubated further at 37°C for 20 min. After incubation, the attached cells were stained with 0.2% crystal violet in 20% methanol for 10 min and counted under the microscope.
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